Peter Soukas Assistant Professor of Medicine (Clinical)

Dr. Peter A. Soukas is the Director of Vascular Medicine and the Interventional Vascular Laboratories at The Miriam and Rhode Island Hospitals. He is also the director of the Vascular & Endovascular Medicine Fellowship Program, training the next generation of cardiovascular medicine specialists.

Dr. Soukas' clinical research interests include carotid stenting and the interventional treatment of peripheral vascular disease. He was the leading New England enroller in the landmark NINDS- sponsored CREST trial, that randomized carotid stenting vs. carotid endarterectomy. Additionally, he has been involved in over 17 carotid trials. His other major interest has been in the role of embolic protection for renal artery stenosis, and was an investigator for the VIVA-Fortress trial, which utilized the FiberNet embolic protection device.

Dr. Soukas is a recognized expert on the interventional treatment of chronic limb ischemia with controlled micro-dissection and needle lumen re-entry devices, novel design peripheral stents, as well as orbital, laser and directional atherectomy devices. In Dr. Soukas' lab, arterial and venous thrombosis is aggressively treated with new pharmaco-mechanical thombectomy devices including the AngioJet power-pulse spray, EKOS ultrasound assisted and the Trellis-8 occlusion catheters.

Brown Affiliations

Research Areas

research overview

Dr. Soukas is actively involved in cardiovascular clinical research, particularly in the areas of carotid stenting, renal stenting with embolic protection, and the treatment of lower extremity limb ischemia using novel devices. He has been a site principal investigator in over 50 clinical research trials, and has lectured at many national and international scientific sessions on various topics involving vascular and endovascular medicine.

research statement

Dr. Soukas has been actively involved as a site principal investigator in the field of carotid stenting. He was the leading New England enroller in the NINDS-sponsored landmark CREST Trial, a randomized trial of endarterectomy vs. stenting with embolic protection. He's been a site investigator in the EPIC, SONOMA, PROTECT, SAPPHIRE, SAPPHIRE-WW, EXACT, ARCHER, CREATE, CREATE-PAS, CARES, CHOICE, EMBOLDEN, CASES, FREEDOM and CANOPY carotid stent trials.

Dr. Soukas has been involved in the the evaluation of renal artery stenting and embolic protection. He's been a site investigator for the CORAL, Florence and VIVA-Fortress renal trials, and will be a site investigator in the ARTISAN renal stent trial to evaluate the safety and efficacy of covered stents for the treatment of renal artery stenosis.

Dr. Soukas has been actively involved in the evaluation of novel treatments for the treatment of lower extremity disease. He's been a site principal investigator in the Superb, Bioflex, VIPER and Open trials, to evaluate novel stent designs for the femoro-popliteal arterial segment, and will be investigating the novel Tigris stent in an upcoming trial. He's been a site PI for the Definitive-LE trial evaluating the role of plaque excisional atherectomy. Dr. Soukas is a site PI for the PEARL registry for the treatment of arterial and venous thrombosis using mechanical thrombectomy, and will be investigating the role of ultrasound-assisted thrombolysis for the treatment of pulmonary embolism in patients with submissive pulmonary embolism.

funded research

N/A